Cargando…

Epigallocatechin gallate attenuates tumor necrosis factor (TNF)-α-induced inhibition of osteoblastic differentiation by up-regulating lncRNA TUG1 in osteoporosis

Promoting osteoblast proliferation and differentiation contributes to the prevention and clinical treatment of osteoporosis. This study was to investigate the effect and mechanism of epigallocatechin gallate (EGCG) on tumor necrosis factor (TNF)-α-caused inhibition of osteoblastic differentiation. F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Yanfeng, Pei, Dening, Li, Wenjing, Luo, Bin, Jiang, Qingsong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161859/ https://www.ncbi.nlm.nih.gov/pubmed/35358011 http://dx.doi.org/10.1080/21655979.2022.2056825

Ejemplares similares

LncRNA TUG1 was upregulated in osteoporosis and regulates the proliferation and apoptosis of osteoclasts
por: Han, Ye, et al.
Publicado: (2019)

Retraction Note: LncRNA TUG1 was upregulated in osteoporosis and regulates the proliferation and apoptosis of osteoclasts
por: Han, Ye, et al.
Publicado: (2020)

Emodin inhibits the progression of acute pancreatitis via regulation of lncRNA TUG1 and exosomal lncRNA TUG1
por: Wen, Xiumei, et al.
Publicado: (2021)

LncRNA PTCSC3 is upregulated in osteoporosis and negatively regulates osteoblast apoptosis
por: Liu, Xingchao, et al.
Publicado: (2022)

(−)-Epigallocatechin gallate but not chlorogenic acid suppresses EGF-stimulated migration of osteoblasts via attenuation of p38 MAPK activity
por: Kawabata, Tetsu, et al.
Publicado: (2018)

LncRNA TUG1 is upregulated and promotes cell proliferation in osteosarcoma
por: Yun-Bo, Feng, et al.
Publicado: (2016)

Epigallocatechin-3-Gallate Ameliorates Glucocorticoid-Induced Osteoporosis of Rats in Vivo and in Vitro
por: Liu, Shengye, et al.
Publicado: (2018)

The Tug1 lncRNA locus is essential for male fertility
por: Lewandowski, Jordan P., et al.
Publicado: (2020)

Epigallocatechin Gallate Attenuates Gentamicin-Induced Nephrotoxicity by Suppressing Apoptosis and Ferroptosis
por: Yue, Lin, et al.
Publicado: (2022)

lncRNA TUG1 promotes proliferation and differentiation of osteoblasts by regulating the miR-545-3p/CNR2 axis
por: Hao, Ruizheng, et al.
Publicado: (2020)

Silencing lncRNA TUG1 Alleviates LPS-Induced Mouse Hepatocyte Inflammation by Targeting miR-140/TNF
por: Liu, Qing-Min, et al.
Publicado: (2021)

LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α
por: Yu, Haotao, et al.
Publicado: (2019)

Skin Protective Effect of Epigallocatechin Gallate
por: Kim, Eunji, et al.
Publicado: (2018)

Role of Epigallocatechin Gallate in Glucose, Lipid, and Protein Metabolism and L-Theanine in the Metabolism-Regulatory Effects of Epigallocatechin Gallate
por: Lin, Ling, et al.
Publicado: (2021)

lncRNA WT1-AS is upregulated in osteoporosis and regulates the apoptosis of osteoblasts by interacting with p53
por: Wang, Chaoqun, et al.
Publicado: (2021)

LncRNA TUG1 promotes the development of osteosarcoma through RUNX2
por: Sheng, Kunkun, et al.
Publicado: (2019)

Fluid shear stress regulates osteoblast proliferation and apoptosis via the lncRNA TUG1/miR‐34a/FGFR1 axis
por: Wang, Xingwen, et al.
Publicado: (2021)

Epigallocatechin gallate attenuates L-DOPA-induced apoptosis in rat PC12 cells
por: Lee, Myung-Yul, et al.
Publicado: (2013)

Epigallocatechin-3-Gallate Attenuates Myocardial Dysfunction via Inhibition of Endothelial-to-Mesenchymal Transition
por: Kim, Sejin, et al.
Publicado: (2023)

Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy
por: Granja, Andreia, et al.
Publicado: (2016)

Food-Grade Encapsulation Systems for (−)-Epigallocatechin Gallate
por: Shi, Meng, et al.
Publicado: (2018)

Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems
por: Granja, Andreia, et al.
Publicado: (2017)

Effect of Epigallocatechin Gallate on Viability of Kudoa septempunctata
por: Shin, Sang Phil, et al.
Publicado: (2020)

PGC1α is required for the renoprotective effect of lncRNA Tug1 in vivo and links Tug1 with urea cycle metabolites
por: Li, Li, et al.
Publicado: (2021)

Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
por: Xie, Qianjin, et al.
Publicado: (2021)

Dysregulated lncRNA TUG1 in different pulmonary artery cells under hypoxia
por: Lv, Zhenchun, et al.
Publicado: (2021)

Involvement of lncRNA TUG1 in HIV-1 Tat-Induced Astrocyte Senescence
por: Pillai, Prakash P., et al.
Publicado: (2023)

The pathogenic roles of lncRNA-Taurine upregulated 1 (TUG1) in colorectal cancer
por: Azizidoost, Shirin, et al.
Publicado: (2022)

The effect of (-)-epigallocatechin gallate as an adjunct to non-surgical periodontal treatment: a randomized clinical trial
por: Zeng, Jiajun, et al.
Publicado: (2022)

Epigallocatechin-3-gallate and Epigallocatechin-3-O-(3-O-methyl)-gallate Enhance the Bonding Stability of an Etch-and-Rinse Adhesive to Dentin
por: Yu, Hao-Han, et al.
Publicado: (2017)

Attenuation of muscle wasting in murine C(2)C(12) myotubes by epigallocatechin-3-gallate
por: Mirza, Kamran A., et al.
Publicado: (2014)

(−)-Epigallocatechin Gallate Targets Notch to Attenuate the Inflammatory Response in the Immediate Early Stage in Human Macrophages
por: Wang, Tengfei, et al.
Publicado: (2017)

LncRNA ROR/miR-145-5p axis modulates the osteoblasts proliferation and apoptosis in osteoporosis
por: Fu, Yin, et al.
Publicado: (2021)

Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion
por: Chan, Chi-Ming, et al.
Publicado: (2010)

Broad inhibition of plasmodium falciparum cytoadherence by (+)-epigallocatechin gallate
por: Patil, Pradeep R, et al.
Publicado: (2011)

Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
por: Singh, Neha Atulkumar, et al.
Publicado: (2016)

Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer
por: Wang, Liu-Xiang, et al.
Publicado: (2019)

The Effect of Ultrasound, Oxygen and Sunlight on the Stability of (−)-Epigallocatechin Gallate
por: Zeng, Jiajun, et al.
Publicado: (2018)

Melatonin and (−)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer
por: Zhang, Lingyun, et al.
Publicado: (2019)

Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate
por: Min, Kyoung-jin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pib0a6ohdqql4lu30vkdua7ud1